Advertisement

Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px
Organisation › Details

Cell Signaling Technology (CST) (Group)

Cell Signaling Technology, Inc. is dedicated to delivering the world's highest quality research, diagnostic, and therapeutic products to accelerate biological understanding and enable personalized medicine. Through its proprietary monoclonal antibody technology, NG-XMT™, and PTMScan® proteomics technology, CST continues to be at the forefront of applied systems biology research, promoting greater understanding of biochemical aberrations that underlie critical diseases, including cancer. CST has made significant discoveries in cancer research through its internal research group, and from this has built an intellectual property portfolio around biomarkers relevant to non-small cell lung cancer. *

 

Period Start 1999-01-01 splitoff
  Today Cell Signaling Technology Inc. (CST)
Products Industry antibody
  Industry 2 proteomic technology
     
  City 01923 Danvers, MA
    Address record changed: 2020-12-02
     
Basic data Employees D: 101 to 500 (2013-06-08)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-09-23

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Cell Signaling Technology (CST) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top